Validation of Body Image Relationship Scale for women with breast cancer

To validate the instrument Body Image Relationship Scale (BIRS) for Brazilian women with breast cancer. The instrument was administered by trained interviewers to 139 women who used the Brazilian Unified Health System (SUS). All of them had been submitted to cancer treatments between 2006 and 2010....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista Brasileira de ginecologia e obstetrícia 2015-10, Vol.37 (10), p.473-479
Hauptverfasser: Vieira, Elisabeth Meloni, dos Santos, Manoel Antônio, Santos, Daniela Barsotti, Mancini, Marina Pasquali Marconato, de Souza, Hayala Cristina Cavenague, Bazan, Jorge Luis, Perdoná, Gleici Da Silva Castro
Format: Artikel
Sprache:por
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To validate the instrument Body Image Relationship Scale (BIRS) for Brazilian women with breast cancer. The instrument was administered by trained interviewers to 139 women who used the Brazilian Unified Health System (SUS). All of them had been submitted to cancer treatments between 2006 and 2010. The instrument was validated considering internal consistency and reliability. In order to compare the techniques, the same factorial analysis as used in the original paper was carried out. The Spearman-Brown correlation value was 0.8, indicating high internal reliability. The Cronbach's alpha found was 0.9, indicating a high level of internal consistency. Factorial analysis showed that four items had low factorial load and no discriminatory power, and another five items were relocated to other factors. When the instrument was applied, it showed variability to that of the original instrument. The Brazilian version of the Body Image Relationship Scale (BIRS), named Escala de Relacionamento e Imagem Corporal (ERIC), showed evidence of adequate reliability and internal consistency, making this instrument suitable to be recommended for application to Brazilian women with breast cancer, despite some limitations.
ISSN:1806-9339
DOI:10.1590/SO100-720320150005354